Women with epilepsy: hormonal issues from menarche through menopause. (Q36896245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Women with epilepsy: hormonal issues from menarche through menopause (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Joyce A Cramer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jacki Gordon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Steven Schachter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

26 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

160-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

Marriage and fertility in epileptic patients

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Characterization of reproductive endocrine disorders in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Likelihood of Pregnancy in Individuals with Idiopathic/Cryptogenic Epilepsy: Social and Biologic Influences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for reduced fertility in marriage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Fertility in persons with epilepsy: 1935-1974.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Menstrual disorders in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Sexual hormones and epilepsy: threat and opportunities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The role of estrogens in catamenial exacerbation of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Progesterone therapy in women with complex partial and secondary generalized seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Progesterone therapy in women with epilepsy: a 3-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Estrogens and epilepsy: why are we so excited?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The role of estrogens in seizures and epilepsy: the bad guys or the good guys?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Catamenial epilepsy: pathophysiology, diagnosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Altered pulsatile secretion of luteinizing hormone in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The anticonvulsant effects of progesterone and 5alpha-dihydroprogesterone on amygdala-kindled seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproductive endocrine considerations and hormonal therapy for women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Hormonal Changes in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Treatment of women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Interactions between antiepileptic drugs and hormonal contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Temporal distribution of seizures in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Catamenial epilepsy: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Three patterns of catamenial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Hormonal effects on epilepsy in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

How common is catamenial epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Phenytoin pharmacokinetics in catamenial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Letter: Modification of therapy for exacerbation of seizures during menstruation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Acetazolamide therapy in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Acetazolamide in women with catamenial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Intermittent clobazam for catamenial epilepsy: tolerance avoided

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Treatment of menstrual epilepsy with a progesterone-only oral contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Role of neurosteroids in catamenial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Sexual dysfunction in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Self-reported sexual function and sexual arousability in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Sexuality in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reduction of Sexual Activities in Females Taking Antiepileptic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Psychoneuroendocrine aspects of temporolimbic epilepsy. Part II: Epilepsy and reproductive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Ovulatory Function in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Predictors of ovulatory failure in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproductive dysfunction in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Sexual dysfunction in partial epilepsy: a deficit in physiologic sexual arousal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Sexual function in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

In VivoMetabolism of Progestins. V. The Effect of Protocol Design on the Estimated Metabolic Clearance Rate and Volume of Distribution of Medroxyprogesterone Acetate in Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effect of lamotrigine on sexual function in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Premature ovarian failure in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Valproate and the polycystic ovarian syndrome: final thoughts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproductive endocrine disorders in women with primary generalized epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Obesity and endocrine disorders in women taking valproate for epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

On the association between valproate and polycystic ovary syndrome: a response and an alternative view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Population based, prospective study of the care of women with epilepsy in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Understanding the information needs of women with epilepsy at different lifestages: results of the 'Ideal World' survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Analysis of prenatal and gestational care given to women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Gender difference in management of epilepsy-what women are hearing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The impact of antiepileptic drug therapy on steroidal contraceptive efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Guidelines for the care of women of childbearing age with epilepsy. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

New antiepileptic drugs: review on drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Do Anticonvulsants Reduce the Efficacy of Oral Contraceptives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Clinical Implications of Enzyme Induction and Enzyme Inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Pregabalin pharmacology and its relevance to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Oral contraceptives reduce lamotrigine plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double-blind, Placebo-controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Contraception for women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

FFPRHC Guidance (July 2005): The use of contraception outside the terms of the product licence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Ethosuximide: liver enzyme induction and D-glucaric acid excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Interactions between anticonvulsants and other commonly prescribed drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Clinical pharmacology of topiramate: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

FFPRHC Guidance (April 2005). Drug interactions with hormonal contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Antiepileptic drug regimens and major congenital abnormalities in the offspring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Teratogenicity of antiepileptic drugs: state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Malformation rates in children of women with untreated epilepsy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

7 January 2021

Pregnancy and epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Seizure disorders in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Guidelines for the care of women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

A maternal complex partial seizure in labor can affect fetal heart rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Reproductive and metabolic disorders in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The importance of monotherapy in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Birth outcomes in women exposed to anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Pregnancy in the woman with epilepsy: maternal and fetal outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Management of epilepsy in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Recent advances on neural tube defects with special reference to Valproic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Management issues for women with epilepsy: neural tube defects and folic acid supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Teratogenicity of antiepileptic drugs: analysis of possible risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Oxcarbazepine concentrations during pregnancy: A retrospective study in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The teratogenicity of anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Congenital malformations due to antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

In utero antiepileptic drug exposure: fetal death and malformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Normal intelligence in children with prenatal exposure to carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Additional educational needs in children born to mothers with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The longer term outcome of children born to mothers with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Increased rate of major malformations in offspring exposed to valproate during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The AED (antiepileptic drug) pregnancy registry: a 6-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The fetal hydantoin syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Spina bifida in infants of women treated with carbamazepine during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Valproic acid in epilepsy : pregnancy-related issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Neuropsychological effects of exposure to anticonvulsant medication in utero

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Major malformations in offspring of women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Lamotrigine and the risk of malformations in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Lamotrigine and the risk of malformations in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Safety of zonisamide therapy: prospective follow-up survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Pregnancy in women who have epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Primary generalized epilepsy: a risk factor for seizures in labor and delivery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The impact of pregnancy and childbirth on the metabolism of lamotrigine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Drug therapy for breast-feeding women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Concerns regarding lamotrigine and breast-feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The effect of menopause and perimenopause on the course of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Seizure frequency is associated with age at menopause in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Effects of menopause on seizures in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Characterization and health risk assessment of postmenopausal women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Hormone Replacement Therapy in Women with Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Lamotrigine clearance during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

2005 AES annual course: evidence used to treat women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Incidence of Fractures among Epilepsy Patients: A Population-based Retrospective Cohort Study in the General Practice Research Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Epilepsy, osteoporosis and fracture risk - a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Risk of extremity fractures in adult outpatients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Fracture risk associated with use of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Fractures, epilepsy, and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Antiepileptic drug use increases rates of bone loss in older women: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Menopause and bone density issues for women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

The Association Between Antiepileptic Drugs and Bone Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Antiepileptic drugs and reduced bone mineral density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Treatment of anticonvulsant drug-induced bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Anticonvulsant-induced bone disease: a plea for monitoring and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.007

10.1016/J.YEBEH.2007.03.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17662661%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference